Arlington Scientific

Arlington Scientific is a privately held diagnostics company that has established itself as a global authority in syphilis testing. Its flagship product is the ASI Evolution SR, the world's first and only FDA-cleared fully automated system for nontreponemal (RPR) syphilis testing, approved for diagnostic, blood donor, and cadaveric tissue screening. The company leverages over 40 years of manufacturing expertise, producing over 30 million RPR tests annually for more than 1,200 labs, and maintains a diversified portfolio including ELISA kits, blocking buffers, and donor lounges. ASI's business model is commercial and revenue-generating, focused on providing comprehensive solutions to a global healthcare market facing a resurgence in syphilis cases.

Proprietary serology platform centered on the ASI Evolution SR, the world's first fully automated system for nontreponemal (RPR) syphilis testing, utilizing the ASI Agglutination Serology Interpretation™ algorithm. Supported by in-house manufacturing of key reagents like carbon antigen and expertise in mercury-free RPR test formulation.

ASI competes in the syphilis testing market against large, diversified diagnostics companies (e.g., Abbott, Roche, Siemens Healthineers) that offer treponemal immunoassays, and other suppliers of manual RPR/VDRL tests. Its primary competitive advantage is the ASI Evolution SR, which has no direct competitor as the only fully automated RPR system FDA-cleared for donor and cadaveric screening. In blocking buffers and OEM services, it faces competition from specialized reagent suppliers.